This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: The Innovative Contributions of Ming-Jo Hsu
Introduction
Ming-Jo Hsu is a notable inventor based in Edison, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents against fungal and parasitic infections. His work is characterized by a focus on protein elongation factors, which play a crucial role in cellular processes.
Latest Patents
Ming-Jo Hsu holds a patent titled "Protein elongation factor 2 as a target for antifungal and antiparasitic." This patent highlights the inhibition of protein elongation factor 2 as a promising target for identifying potential antifungal and antiparasitic compounds. The findings suggest that EF2 inhibitors can serve as effective therapeutic agents against various fungal and parasitic infections. He has 1 patent to his name.
Career Highlights
Ming-Jo Hsu is currently employed at Merck & Co., Inc., a leading global healthcare company. His role at Merck allows him to engage in cutting-edge research and development, contributing to the advancement of medical science and public health.
Collaborations
Ming-Jo has collaborated with several talented individuals in his field, including Jennifer Nielsen-Kahn and Michael C Justice. These collaborations have fostered a productive environment for innovation and discovery.
Conclusion
Ming-Jo Hsu's work exemplifies the impact of innovative research in the fight against infectious diseases. His contributions to the understanding of protein elongation factors are paving the way for new therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile